Individuals with HIV who were resistant to all four antiretroviral drug classes experienced higher mortality than those who were not resistant, a difference primarily due to lower CD4 cell counts.
Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. A twice-yearly injection of a drug known as lenacapavir offered ...
(Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) submission for bictegravir 75 mg/lenacapavir 50 mg (BIC/LEN) – an investigational, ...
Gilead has developed a 1-every-6-month injection to prevent HIV. The medication will sell for $14,000 a shot. With numerous proposed major cuts to Medicaid and the Affordable Care Act in congress, ...
Len is a gamechanging drug to prevent HIV infections, priced by Gilead at $28,200. Limited drug is available at cost to ...
Human immunodeficiency virus or HIV is a virus that makes your immune system so weak that it becomes hard for it to fight off even minor illnesses. That's why people affected by this virus get ...
Prefer Newsweek on Google to see more of our trusted coverage when you search. One sweltering California afternoon a few weeks ago, Christine Maggiore was sitting in her cramped office, still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results